Evidence map›Paper›PMID 36008980›Full record

ArticleBiomolecules2022

MTHFR SNPs (Methyl Tetrahydrofolate Reductase, Single Nucleotide Polymorphisms) C677T and A1298C Prevalence and Serum Homocysteine Levels in >2100 Hypofertile Caucasian Male Patients

Arthur Clément, Edouard Amar, Charles Brami, Patrice Clément, Silvia Alvarez, Laetitia Jacquesson-Fournols, Céline Davy, Marc Lalau-Keraly, Yves Menezo

Abstract read
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Susceptibility to hypertension based onFrontiers in cardiovascular medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Arthur ClémentLaboratoire CLEMENT, 75016 Paris, France.
Edouard AmarAmerican Hospital, 92200 Paris, France.
Charles BramiAmerican Hospital, 92200 Paris, France.
Patrice ClémentLaboratoire CLEMENT, 75016 Paris, France.ORCID 0000-0001-8449-1035
Silvia AlvarezCabinet Medical, 15 Avenue Poincarré, 75016 Paris, France.
Laetitia Jacquesson-FournolsCabinet Médical Endocrinologie, 40 boulevard de Courcelles, 75017 Paris, France.ORCID 0000-0003-3017-0695
Céline DavyCabinet Médical Endocrinologie, 40 boulevard de Courcelles, 75017 Paris, France.
Marc Lalau-KeralyCabinet Médical, 34 Avenue d'Eylau, 75016 Paris, France.
Yves MenezoLaboratoire CLEMENT, 75016 Paris, France.ORCID 0000-0001-6861-8905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylation is a crucially important ubiquitous biochemical process, which covalently adds methyl groups to a variety of molecular targets. It is the key regulatory process that determines the acquisition of imprinting and epigenetic marks during gametogenesis. Methylation processes are dependent upon two metabolic cycles, the folates and the one-carbon cycles. The activity of these two cycles is compromised by single nucleotide polymorphisms (SNPs) in the gene encoding the Methylenetetrahydrofolate reductase (MTHFR) enzyme. These SNPs affect spermatogenesis and oocyte maturation, creating cytologic/chromosomal anomalies. The two main MTHFR SNP variants C677T (c.6777C>T) and A1298C (c.1298A>C) together with serum homocysteine levels were tested in men with >3 years’ duration of infertility who had failed several ART attempts with the same partner. These patients are often classified as having “idiopathic infertility”. We observed that the genetic status with highest prevalence in this group is the heterozygous C677T, followed by the combined heterozygous C677T/A1298C, and then A1298C; these three variants represent 65% of our population. Only 13.1% of the patients tested are wild type (WT), C677C/A1298A). The homozygous 677TT and the combined heterozygote 677CT/1298AC groups have the highest percentage of patients with an elevated circulating homocysteine level of >15 µMolar (57.8% and 18.8%, respectively, which is highly significant for both). Elevated homocysteine is known to be detrimental to spermatogenesis, and the population with this parameter is not marginal. In conclusion, determination of these two SNPs and serum homocysteine should not be overlooked for patients with severe infertility of long duration, including those with repeated miscarriages. Patients must also be informed about pleiotropic medical implications relevant to their own health, as well as to the health of future children.

Indexed as

InfertilityMethylenetetrahydrofolate Reductase (NADPH2)Genetic Predisposition to DiseaseGenotypeHomocysteineHumansMalePolymorphism, Single NucleotidePrevalenceTetrahydrofolatesHomocysteineMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanTetrahydrofolatesA1298CC677TCaucasian men populationhomocysteinehypofertilityMTHFR SNP

Identifiers

PMID36008980
PMCPMC9405832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.